
Ashwin Balagopal MD
Associate Professor of Medicine, Johns Hopkins University School of Medicine
Join to View Full Profile
1717 East Monument StreetPark Building, Ground LevelBaltimore, MD 21287
Phone+1 410-955-1725
Fax+1 443-287-4173
Dr. Balagopal is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- Johns Hopkins UniversityFellowship, Infectious Disease, 2006 - 2009
- Yale-New Haven Medical CenterResidency, Internal Medicine, 2000 - 2004
- Icahn School of Medicine at Mount SinaiClass of 2000
Certifications & Licensure
- MD State Medical License 2009 - 2026
- OH State Medical License 2004 - 2011
- CT State Medical License 2003 - 2004
- American Board of Internal Medicine Infectious Disease
Publications & Presentations
PubMed
- High-dimensional droplet digital PCR of multiple hepatitis B splice variants in serum, liver, and tissue culture.Tanner Grudda, Chenkai Jiang, Che-Min Lo, Nicole E Skinner, Mark S Sulkowski
Journal of Virological Methods. 2025-04-08 - Transcription of hepatitis B surface antigen shifts from cccDNA to integrated HBV DNA during treatment.Maraake Taddese, Tanner Grudda, Giulia Belluccini, Mark Anderson, Gavin Cloherty
The Journal of Clinical Investigation. 2025-01-30 - 1 citationsHepatitis B Virus DNA and RNA Persist in Liver After Serologic Recovery in Persons With Hepatitis C Virus.Tanner Grudda, David L Thomas, Gregory D Kirk, Shruti H Mehta, Jacquie Astemborski
The Journal of Infectious Diseases. 2024-12-16
Press Mentions
- Merck’s Covid Pill Might Pose Risks for Pregnant WomenDecember 13th, 2021
- HIV in Liver Cells Found to Be Inactive, Narrowing Potential Treatment TargetsNovember 29th, 2018
- No 'Reservoir': Detectable HIV-1 in Treated Human Liver Cells Found to Be InertOctober 1st, 2018
- Join now to see all
Grant Support
- HBV cccDNA transcriptional silencing with and without HIVJOHNS HOPKINS UNIVERSITY2024–2029
- HBV cccDNA transcriptional silencing with and without HIVJOHNS HOPKINS UNIVERSITY2024–2029
- HBV cccDNA transcriptional silencing with and without HIVJOHNS HOPKINS UNIVERSITY2024–2029
- HBV cccDNA transcriptional silencing with and without HIVJOHNS HOPKINS UNIVERSITY2024–2029
- HBV cccDNA transcriptional silencing with and without HIVJOHNS HOPKINS UNIVERSITY2024–2029
- NIH: Spatial Models of Intrahepatic Hepatitis Virus Propagation in HumansTRIAD NATIONAL SECURITY, LLC2022–2027
- NIH: Spatial Models of Intrahepatic Hepatitis Virus Propagation in HumansTRIAD NATIONAL SECURITY, LLC2022–2027
- Unraveling sources of hepatitis B surface antigen before and after nucleos(t)ide analogue treatment in People with HIVJOHNS HOPKINS UNIVERSITY2021–2025
- Mechanisms of HBV cccDNA transcriptional regulation in persons with and without HIVJOHNS HOPKINS UNIVERSITY2018–2025
- HIV, Kupffer Cells, And Hcv-Related Liver FibrosisNational Institute Of Allergy And Infectious Diseases2009–2011
Other Languages
- Tamil
External Links
- Johns Hopkins Physicianshttp://www.hopkinsmedicine.org/ashwin-balagopal
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: